RNU6-307P

Across TCGA pan-cancer cohorts, RNU6-307P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RNU6-307P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-307P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-307P expression acts as an unfavorable survival marker, although some lineages such as CESC and BLCA show a favorable association.

STAD, KICH, and OV are the cancer types where RNU6-307P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Quartile	IV	0.205	0.595	<.001	74	view →
KICH	DFS	Tertile	III,IV	0.181	0.814	<.001	41	view →
OV	DFS	Tertile	III,IV	0.114	0.170	.019	38	view →
COAD	OS	Tertile	All	0.812	0.891	.004	35	view →
DLBC	DFS	Median	All	0.579	1.000	.007	32	view →
CESC	OS	Median	III,IV	0.894	0.642	.005	30	view →
KIRC	DFS	Tertile	IV	0.213	0.390	.012	30	view →
UVM	OS	Tertile	III,IV	0.246	0.677	.023	19	view →
THCA	DFS	Quartile	III,IV	0.835	0.908	.016	18	view →
PRAD	DFS	Tertile	All	0.727	0.825	.009	14	view →
BLCA	OS	Quartile	All	0.817	0.689	.010	13	view →
SARC	OS	Tertile	All	0.912	0.809	.011	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RNU6-307P–STAD (DFS)

Open the STAD breakdown →